The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health.

MLA

Darrow, Jonathan J., et al. “The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health.” New England Journal of Medicine, vol. 378, no. 5, Feb. 2018, pp. 412–14. EBSCOhost, https://doi.org/10.1056/NEJMp1711643.

APA

Darrow, J. J., Fuse Brown, E. C., & Kesselheim, A. S. (2018). The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health. New England Journal of Medicine, 378(5), 412–414. https://doi.org/10.1056/NEJMp1711643

Chicago

Darrow, Jonathan J., Erin C. Fuse Brown, and Aaron S. Kesselheim. 2018. “The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health.” New England Journal of Medicine 378 (5): 412–14. doi:10.1056/NEJMp1711643.